Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2b) on 6p22

E. M. Chan, D. E. Bulman, A. D. Paterson, J. Turnbull, E. Andermann, F. Andermann, G. A. Rouleau, A. V. Delgado-Escueta, S. W. Scherer, B. A. Minassian

Research output: Contribution to journalArticlepeer-review

69 Scopus citations


Background: Lafora disease is a progressive myoclonus epilepsy with polyglucosan accumulations and a peculiar neurodegeneration with generalised organellar disintegration. It causes severe seizures, leading to dementia and eventually death in early adulthood. Methods: One Lafora disease gene, EPM2A, has been identified on chromosome 6q24. Locus heterogeneity led us to search for a second gene using a genome wide linkage scan in French-Canadian families. Results: We mapped a second Lafora disease locus, EPM2B, to a 2.2 Mb region at 6p22, a region known to code for several proteins, including kinesins. Kinesins are microtubule dependent motor proteins that are involved in transporting cellular components. In neurones, they play a major role in axonal and dendritic transport. Conclusion: Analysis of the present locus in other non-EPM2A families will reveal whether there is further locus heterogeneity. Identification of the disease gene will be of major importance towards our understanding of the pathogenesis of Lafora disease.

Original languageEnglish (US)
Pages (from-to)671-675
Number of pages5
JournalJournal of medical genetics
Issue number9
StatePublished - Sep 1 2003

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2b) on 6p22'. Together they form a unique fingerprint.

Cite this